Johnson & Johnson JNJ

271.22 0.54 0.20% as of 25 Sep
Market cap
$652.8B
P/E
31.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

Johnson & Johnson (JNJ) Operating margin

Johnson & Johnson's operating margin over the twelve months to 30 June 2026 was 27.7%, down 9.0 percentage points from fiscal 2025 (36.7%). Over the past ten years it has ranged from 20.1% (fiscal 2023) to 36.7% (fiscal 2025) — the current reading is the highest in ten years. That is above the Drug Manufacturers General industry median of 18.9% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Annual

Period Operating margin Change (points)
FY2025 36.7% 15.60
FY2024 21.1% 1.07
FY2023 20.1% (5.09)
FY2022 25.2% 0.50
FY2021 24.7% 4.31
FY2020 20.4% (1.59)
FY2019 21.9% (2.10)
FY2018 24.0% (0.80)
FY2017 24.8% (4.23)
FY2016 29.1% 0.71

Quarterly

Period Operating margin Change (points)
Jun 2026 28.6% 1.65
Mar 2026 27.0% 4.93
Dec 2025 22.1% (11.15)
Sep 2025 33.2% 3.47
42 more quarters

Against its own ten years

Low 20.1% High 36.7%
Ten-year median 24.7%
Current reading's percentile 100

Operating margin against peers

Company Operating margin
LLY Eli Lilly and Company compare 42.2%
NVS Novartis AG compare 30.2%
AMGN Amgen Inc. compare 30.0%
JNJ Johnson & Johnson 27.7%
ABBV AbbVie Inc. compare 26.2%
AZN AstraZeneca PLC compare 22.8%
PFE Pfizer Inc. compare 21.7%
MRK Merck & Co., Inc. compare 10.5%
GILD Gilead Sciences, Inc. compare −8.20%
Drug Manufacturers General industry median 18.9%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on JNJ